India's Omicron Cases Rise To 358 With 122 In Last 24 Hours
India recorded 122 cases of the Omicron variant of COVID-19 in a span of 24 hours, the highest so far, Pushing its tally in the country to 358. The 358 Omicron Covid variant cases have been detected a...
25 Des 20211min
Covishield Protection Diminishes After 3 Months
The protection 3 offered by the Oxford-Astra Zeneca COVID-19 vaccine Declines after three months of receiving two doses of the preventive, according to a study published in The Lancet journal.
25 Des 20212min
Type 2 DM children at high risk of developing retinopathy
Diabetes is a common chronic disease of childhood characterized by chronic hyperglycemia with end-organ damage that often results in the microvascular triad of nephropathy, neuropathy, and retinopathy...
25 Des 20211min
24-12-21 TOP HEATH NEWS
Doctors Indemnity Not For Hospital: Supreme Court No Faculty In 5 Departments: NMC Inspection Points Out Faculty Shortage At Dumka Medical College Covishield Protection Diminishes After 3 Months: ...
25 Des 20215min
24.12.21 TOP MEDICAL NEWS
Statins reduces risk of ischemic, hemorrhagic stroke Diverse food within 1 year of life reduces allergy risk Oral tofacitinib helps in alopecia areata in children Antiseizure medication tied to ...
25 Des 20215min
23.12.21 TOP MEDICAL NEWS
Faster transmission of the Omicron virus and why third dose might be needed Irregular menses may indicate underlying CVD and diabetes FDA Approves tofacitinib for Treatment of Active Ankylosing Sp...
23 Des 20215min
Dental Anxiety highly prevalent amongst pregnant women
Dental Anxiety is highly prevalent amongst pregnant women, according to a recent study published in the International Dental Journal.
23 Des 20211min
FDA Approves tofacitinib for Treatment of Active Ankylosing Spondylitis
The approval of XELJANZ for AS is based on data from a Phase 3, multicenter, randomized, double-blind, placebo-controlled study that evaluated the efficacy and safety of tofacitinib 5 mg twice daily v...
23 Des 20211min
